학술논문
Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression
Document Type
Article
Author
Source
In Cancer Letters 1 December 2014 355(1):61-69
Subject
Language
ISSN
0304-3835